| RS2109376054 |
SGCB
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Autosomal recessive limb-girdle muscular dystrophy type 2E |
| RS2109377653 |
WDR19
|
Health Risk |
Pathogenic |
Senior-Loken syndrome 8, Asphyxiating thoracic dystrophy 5 |
| RS2109380796 |
SGCB
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Autosomal recessive limb-girdle muscular dystrophy type 2E |
| RS2109380824 |
SGCB
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Autosomal recessive limb-girdle muscular dystrophy type 2E |
| RS2109380910 |
SGCB
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Autosomal recessive limb-girdle muscular dystrophy type 2E |
| RS2109380938 |
SGCB
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Autosomal recessive limb-girdle muscular dystrophy type 2E |
| RS2109380946 |
SGCB
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Autosomal recessive limb-girdle muscular dystrophy type 2E |
| RS2109388978 |
DOK7
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 10, Congenital myasthenic syndrome 10 |
| RS2109395463 |
CACNA2D2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2109400528 |
CACNA2D2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2109400541 |
CACNA2D2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2109405851 |
WDR19
|
Health Risk |
Pathogenic |
Asphyxiating thoracic dystrophy 5, Senior-Loken syndrome 8 |
| RS2109411685 |
CACNA2D2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2109417343 |
DOK7
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 10, Congenital myasthenic syndrome 10 |
| RS2109417797 |
DOK7
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 10, Fetal akinesia deformation sequence 1 |
| RS2109421369 |
CACNA2D2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2109460398 |
OPA1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2109460493 |
OPA1
|
Health Risk |
Pathogenic |
— |
| RS2109488570 |
SRD5A3
|
Health Risk |
Likely pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2109489105 |
SRD5A3
|
Health Risk |
Conflicting classifications of pathogenicity |
SRD5A3-congenital disorder of glycosylation, SRD5A3-congenital disorder of glycosylation |
| RS2109497413 |
WDR19
|
Health Risk |
Likely pathogenic |
Asphyxiating thoracic dystrophy 5, Senior-Loken syndrome 8 |
| RS2109520891 |
KIT
|
Health Risk |
Pathogenic |
— |
| RS2109521864 |
WDR19
|
Health Risk |
Pathogenic |
Spermatogenic failure 72, Spermatogenic failure 72 |
| RS2109523966 |
REST
|
Health Risk |
Pathogenic |
— |
| RS2109573013 |
REST
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 27, Autosomal dominant nonsyndromic hearing loss |
| RS2109578516 |
REST
|
Health Risk |
Pathogenic |
Fibromatosis, gingival |
| RS2109591981 |
CEP63
|
Health Risk |
Likely pathogenic |
Seckel syndrome 6, Seckel syndrome 6 |
| RS2109626303 |
GABRA2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 78 |
| RS2109643293 |
GABRA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2109661936 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS2109671915 |
KIT
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS2109671956 |
KIT
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS2109673896 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS2109674011 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS2109674601 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Cutaneous mastocytosis |
| RS2109692864 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS2109705287 |
KIT
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS2109769912 |
KIT
|
Health Risk |
Likely pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS2109773622 |
KIT
|
Health Risk |
Likely pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS2109775078 |
GRXCR1
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 25, Autosomal recessive nonsyndromic hearing loss 25 |
| RS2109777571 |
KIT
|
Health Risk |
Likely pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS2109779186 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS2109780360 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Gastrointestinal stromal tumor |
| RS2109782285 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS2109792066 |
KIT
|
Health Risk |
Likely pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS2109794784 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS2109794937 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Piebaldism, Hereditary cancer-predisposing syndrome |
| RS2109801456 |
KIT
|
Health Risk |
Pathogenic |
Piebaldism, Piebaldism |
| RS2109810899 |
KIT
|
Health Risk |
Likely pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS2109812419 |
GRXCR1
|
Health Risk |
Pathogenic |
— |
| RS2109812443 |
GRXCR1
|
Health Risk |
Pathogenic |
— |
| RS2109817825 |
ENAM
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, Amelogenesis imperfecta |
| RS2109818086 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Gastrointestinal stromal tumor |
| RS2109818619 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS2109834757 |
FRAS1
|
Health Risk |
Likely pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS2109847651 |
FRAS1
|
Health Risk |
Pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS2109850407 |
FRAS1
|
Health Risk |
Likely pathogenic |
— |
| RS2109856354 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS2109887859 |
LIAS
|
Health Risk |
Pathogenic |
Lipoic acid synthetase deficiency, Lipoic acid synthetase deficiency |
| RS2109933573 |
PRKG2
|
Health Risk |
Pathogenic |
Spondylometaphyseal dysplasia, pagnamenta type |
| RS2109937707 |
SCARB2
|
Health Risk |
Likely pathogenic |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS2109942038 |
SCARB2
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS2109944333 |
SCARB2
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS2109973501 |
TECRL
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 3, Catecholaminergic polymorphic ventricular tachycardia 3 |
| RS2109988131 |
GNRHR
|
Health Risk |
Likely pathogenic |
— |
| RS2109995326 |
DSPP
|
Health Risk |
Pathogenic |
— |
| RS2109996574 |
DSPP
|
Health Risk |
Pathogenic |
— |
| RS2109998972 |
DSPP
|
Health Risk |
Likely pathogenic |
Dentinogenesis imperfecta type 3, Dentinogenesis imperfecta type 3 |
| RS2109999064 |
DSPP
|
Health Risk |
Likely pathogenic |
Dentinogenesis imperfecta type 2, Dentinogenesis imperfecta type 2 |
| RS2110031828 |
HNRNPDL
|
Health Risk |
Likely pathogenic |
— |
| RS2110051822 |
GABRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 45 |
| RS2110080128 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2110087773 |
PRKG2
|
Health Risk |
Pathogenic |
Acromesomelic dysplasia 4, Acromesomelic dysplasia 4 |
| RS2110089194 |
PKD2
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS2110089248 |
PKD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant polycystic kidney disease, Polycystic kidney disease 2 |
| RS2110104722 |
PKD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Squamous cell lung carcinoma, PKD2-related disorder |
| RS2110104725 |
PKD2
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS2110104830 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2110104859 |
PKD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2110104877 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Autosomal dominant polycystic kidney disease |
| RS2110107069 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2110107236 |
PKD2
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Polycystic kidney disease 2 |
| RS2110107239 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2110107353 |
PKD2
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2110109074 |
ANTXR2
|
Health Risk |
Likely pathogenic |
Hyaline fibromatosis syndrome, Hyaline fibromatosis syndrome |
| RS2110112018 |
PKD2
|
Health Risk |
Likely pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS2110112037 |
PKD2
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2110112083 |
PKD2
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS2110112181 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2110112194 |
PKD2
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS2110115819 |
PKD2
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Polycystic kidney disease 2 |
| RS2110122856 |
SRP72
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2110127334 |
PKD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease 2, PKD2-related disorder |
| RS2110127572 |
CNGA1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 49, Retinitis pigmentosa 49 |
| RS2110128153 |
CNGA1
|
Health Risk |
Pathogenic |
— |
| RS2110128608 |
CNGA1
|
Health Risk |
Pathogenic |
— |
| RS2110129031 |
CNGA1
|
Health Risk |
Pathogenic |
— |
| RS2110129645 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2110129653 |
PKD2
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS2110130838 |
CNGA1
|
Health Risk |
Pathogenic |
— |